KRT19 and breast cancer: Using a published protocol employing highly specific CK19 primers and FRET probes without prior pre-amplification, CK19 transcripts were detected in none of the 26 HD samples, but in 5/60 BC samples (4/19 (21.1%) metastatic BC, 2/41 (4.9%) early BC).